Key summary points
To investigate associations of sarcopenia with adverse health-related outcomes, through an umbrella review method.
AbstractSection FindingsSarcopenia appears to be significantly associated with several adverse outcomes in older people, with a strong evidence for increased risk of mortality, disability, and falls.
AbstractSection MessageSarcopenia is associated with several adverse health-related outcomes in older people, indicating the need of assessing this condition in daily practice.
Abstract
Background
The clinical relevance of sarcopenia has increasingly been recognized. However, whether it is associated with the development of other medical conditions is still unclear. Therefore, we aimed to capture the scale of outcomes that have been associated with the presence of sarcopenia and systematically assess the quality, strength, and credibility of these associations using an umbrella review methodology.
Methods
A systematic review in several databases was carried out, until 20th February 2019. For each association, random-effects summary effect size, 95% confidence intervals (CIs), heterogeneity (I2), evidence for small-study effect, evidence for excess significance bias, and 95%-prediction intervals were estimated. We used these metrics to categorize the evidence of significant outcomes (p < 0.05) from class I (convincing) to class IV (weak), according to pre-established criteria.
Results
From 358 abstracts, 6 meta-analyses with 14 associations were included. Sarcopenia was associated with higher risk of other comorbidities and mortality in 11 of 14 outcomes explored. However, only 3 outcomes (i.e., association between sarcopenia and increased risk of death in community-dwelling older people [odds ratio, OR = 3.60; 95% CI 2.96–4.37; n = 14,305], disability [OR = 3.04; 95% CI 1.80–5.12; n = 8569], and falls [OR = 1.60; 95% CI 1.31–1.97; n = 12,261]) presented a highly suggestive evidence (class II). Other association was classified as having only a weak evidence.
Conclusion
Sarcopenia is associated with several adverse health-related outcomes in older people, and its associations with mortality, disability, and falls are supported by a highly suggestive evidence. The effect of interventions on sarcopenia to improve these outcomes needs to be investigated.
Similar content being viewed by others
References
Sarcopenia Woo J (2017) Clin Geriatr Med 33(3):305–314
Landi F, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E et al (2012) Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr 31(5):652–658. https://doi.org/10.1016/j.clnu.2012.02.007
Cederholm T, Cruz-Jentoft AJ, Maggi S (2013) Sarcopenia and fragility fractures. Eur J Phys Rehabil Med 49(1):111–117
Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR, Harris TB (2010) Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 21(4):543–559. https://doi.org/10.1007/s00198-009-1059-y
Cesari M, Pahor M, Lauretani F, Zamboni V, Bandinelli S, Bernabei R et al (2009) Skeletal muscle and mortality results from the InCHIANTI Study. J Gerontol Ser A Biol Sci Med Sci 64(3):377–384. https://doi.org/10.1093/gerona/gln031
Gariballa S, Alessa A (2013) Sarcopenia: prevalence and prognostic significance in hospitalized patients. Clin Nutr (Edinb Scotl) 32(5):772–776. https://doi.org/10.1016/j.clnu.2013.01.010
Perkisas S, De Cock A-M, Vandewoude M, Verhoeven V (2018) Prevalence of sarcopenia and 9-year mortality in nursing home residents. Aging Clin Exp Res 31(7):951–959
Rizzoli R, Reginster JY, Arnal JF, Bautmans I, Beaudart C, Bischoff-Ferrari H et al (2013) Quality of life in sarcopenia and frailty. Calcif Tissue Int 93(2):101–120. https://doi.org/10.1007/s00223-013-9758-y
Mayhew A, Amog K, Phillips S, Parise G, McNicholas P, de Souza R et al (2018) The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing 48(1):48–56
Anker SD, Morley JE, von Haehling S (2016) Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle 7(5):512–514
Marzetti E, Calvani R, Tosato M, Cesari M, Di Bari M, Cherubini A et al (2017) Sarcopenia: an overview. Aging Clin Exp Res 29(1):11–17
Dent E, Morley J, Cruz-Jentoft A, Arai H, Kritchevsky S, Guralnik J et al (2018) International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging 22(10):1148–1161
Chindapasirt J (2015) Sarcopenia in cancer patients. Asian Pac J Cancer Prev APJCP 16(18):8075–8077
von Haehling S (2018) Muscle wasting and sarcopenia in heart failure: a brief overview of the current literature. ESC Heart Fail 5(6):1074–1082. https://doi.org/10.1002/ehf2.12388
Jones SE, Maddocks M, Kon SS, Canavan JL, Nolan CM, Clark AL et al (2015) Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax 70(3):213–218. https://doi.org/10.1136/thoraxjnl-2014-206440
Shenkin SD, Harrison JK, Wilkinson T, Dodds RM, Ioannidis JP (2017) Systematic reviews: guidance relevant for studies of older people. Age Ageing 46(5):722–728
Ioannidis JP (2009) Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ 181(8):488–493. https://doi.org/10.1503/cmaj.081086
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4):412–423. https://doi.org/10.1093/ageing/afq034
Chen L-K, Liu L-K, Woo J, Assantachai P, Auyeung T-W, Bahyah KS et al (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15(2):95–101
Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C et al (2007) Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 7(1):10. https://doi.org/10.1186/1471-2288-7-10
Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820–826
Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB et al (2014) The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol Ser A Biomed Sci Med Sci 69(5):547–558
Higgins JP, Thompson SG, Spiegelhalter DJ (2009) A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. 172(1):137–159. https://doi.org/10.1111/j.1467-985X.2008.00552.x
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558. https://doi.org/10.1002/sim.1186
Ioannidis JP, Patsopoulos NA, Evangelou E (2007) Uncertainty in heterogeneity estimates in meta-analyses. BMJ 335(7626):914–916. https://doi.org/10.1136/bmj.39343.408449.80
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634
Carvalho AF, Kohler CA, Brunoni AR, Miskowiak KW, Herrmann N, Lanctot KL et al (2016) Bias in peripheral depression biomarkers. Psychother Psychosom 85(2):81–90. https://doi.org/10.1159/000441457
Ioannidis JP, Trikalinos TA (2007) An exploratory test for an excess of significant findings. Clin Trials 4(3):245–253. https://doi.org/10.1177/1740774507079441
Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P (2015) Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Healthc 13(3):132–140. https://doi.org/10.1097/xeb.0000000000000055
Belbasis L, Savvidou MD, Kanu C, Evangelou E, Tzoulaki I (2016) Birth weight in relation to health and disease in later life: an umbrella review of systematic reviews and meta-analyses. BMC Med 14(1):147. https://doi.org/10.1186/s12916-016-0692-5
Bellou V, Belbasis L, Tzoulaki I, Evangelou E, Ioannidis JP (2016) Environmental risk factors and Parkinson’s disease: an umbrella review of meta-analyses. Parkinsonism Related Disord 23:1–9. https://doi.org/10.1016/j.parkreldis.2015.12.008
Dinu M, Pagliai G, Casini A, Sofi F (2017) Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomized trials. Nutr Metabol Cardiovasc Dis 27(1):e21. https://doi.org/10.1016/j.numecd.2016.11.055
Kyrgiou M, Kalliala I, Markozannes G, Gunter MJ, Paraskevaidis E, Gabra H et al (2017) Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ 356(28):j477. https://doi.org/10.1136/bmj.j477
Li X, Meng X, Timofeeva M, Tzoulaki I, Tsilidis KK, Ioannidis PA et al (2017) Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies. BMJ 357:j2376
Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JPA (2014) Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ Br Med J 348:g2035
Veronese N, Solmi M, Caruso MG, Giannelli G, Osella AR, Evangelou E et al (2018) Dietary fiber and health outcomes: an umbrella review of systematic reviews and meta-analyses. Am J Clin Nutr 107(3):436–444. https://doi.org/10.1093/ajcn/nqx082
Zhang X, Huang P, Dou Q, Wang C, Zhang W, Yang Y et al (2019) Falls among older adults with sarcopenia dwelling in nursing home or community: a meta-analysis. Clin Nutr (Edinb Scotl) 25:25. https://doi.org/10.1016/j.clnu.2019.01.002
Zhang Y, Hao Q, Ge M, Dong B (2018) Association of sarcopenia and fractures in community-dwelling older adults: a systematic review and meta-analysis of cohort studies. Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 29(6):1253–1262. https://doi.org/10.1007/s00198-018-4429-5
Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyere O (2017) Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One 12(1):e0169548. https://doi.org/10.1371/journal.pone.0169548
Zhao Y, Zhang Y, Hao Q, Ge M, Dong B (2019) Sarcopenia and hospital-related outcomes in the old people: a systematic review and meta-analysis. Aging Clin Exp Res 31(1):5–14. https://doi.org/10.1007/s40520-018-0931-z
Yang Z, Zhou X, Ma B, Xing Y, Jiang X, Wang Z (2018) Predictive value of preoperative sarcopenia in patients with gastric cancer: a meta-analysis and systematic review. J Gastrointest Surg Off J Soc Surg Aliment Tract 22(11):1890–1902. https://doi.org/10.1007/s11605-018-3856-0
Zhang X, Wang C, Dou Q, Zhang W, Yang Y, Xie X (2018) Sarcopenia as a predictor of all-cause mortality among older nursing home residents: a systematic review and meta-analysis. BMJ Open 8(11):e021252. https://doi.org/10.1136/bmjopen-2017-021252
Sayer AA (2014) Sarcopenia the new geriatric giant: time to translate research findings into clinical practice. Br Geriatr Soc 43(6):736–737
Beaudart C, Rolland Y, Cruz-Jentoft A, Bauer J, Sieber C, Cooper C et al (2019) Assessment of Muscle Function and Physical Performance in Daily Clinical Practice: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Calcif Tissue Int. https://doi.org/10.1007/s00223-019-00545-w
Cruz-Jentoft AJ, Sayer AA (2019) Sarcopenia. Lancet 393(10191):2636–2646. https://doi.org/10.1016/S0140-6736(19)31138-9
Calvani R, Marini F, Cesari M, Tosato M, Anker SD, Von Haehling S et al (2015) Biomarkers for physical frailty and sarcopenia: state of the science and future developments. J Cachexia Sarcopenia Muscle 6(4):278–286. https://doi.org/10.1002/jcsm.12051
Cruz-Jentoft AJ, Kiesswetter E, Drey M, Sieber CC (2017) Nutrition, frailty, and sarcopenia. Aging Clin Exp Res 29(1):43–48
Bano G, Trevisan C, Carraro S, Solmi M, Luchini C, Stubbs B et al (2017) Inflammation and sarcopenia: a systematic review and meta-analysis. Maturitas 96:10–15. https://doi.org/10.1016/j.maturitas.2016.11.006
Can B, Kara O, Kizilarslanoglu MC, Arik G, Aycicek GS, Sumer F et al (2017) Serum markers of inflammation and oxidative stress in sarcopenia. Aging Clin Exp Res 29(4):745–752
Dunn JE, Rudberg MA, Furner SE, Cassel CK (1992) Mortality, disability, and falls in older persons: the role of underlying disease and disability. Am J Public Health 82(3):395–400
Du Y, Karvellas CJ, Baracos V, Williams DC, Khadaroo RG, Group ESA (2014) Sarcopenia is a predictor of outcomes in very elderly patients undergoing emergency surgery. Surgery 156(3):521–527
Anker MS, Von Haehling S, Springer J, Banach M, Anker SD (2013) Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology. Int J Cardiol 162(2):73–76
Joglekar S, Nau PN, Mezhir JJ (2015) The impact of sarcopenia on survival and complications in surgical oncology: a review of the current literature. J Surg Oncol 112(5):503–509
Ioannidis JP, Patsopoulos NA, Rothstein HR (2008) Reasons or excuses for avoiding meta-analysis in forest plots. BMJ 336(7658):1413–1415. https://doi.org/10.1136/bmj.a117
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
All authors declare no conflict of interest.
Ethical approval
It was not requested being a revision of already published literature.
Informed consent
No patients were included in this review.
Sponsor’s role
None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Veronese, N., Demurtas, J., Soysal, P. et al. Sarcopenia and health-related outcomes: an umbrella review of observational studies. Eur Geriatr Med 10, 853–862 (2019). https://doi.org/10.1007/s41999-019-00233-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s41999-019-00233-w